BackSyros Pharmaceuticals Overview
Syros Pharmaceuticals Inc.

Syros Pharmaceuticals Discounted Cash Flow

DCF Analysis for SYRS.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$6.67

Current Fair Value

$6.67
6674200.0% Upside

Undervalued by 6674200.0% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading